" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

13th Annual SoCalBio Conference

Southern California Biomedical Council

Wednesday, November 9, 2011 from 7:00 AM to 7:00 PM (PST)

13th Annual SoCalBio Conference

Ticket Information

Ticket Type Sales End Price Fee Quantity
Not a SoCalBio Member Ended $450.00 $23.45
SoCalBio Member Ended $300.00 $17.49
Institutional and Angel Investors Ended $300.00 $17.49
Academic/Gov./Nonprofit Ended $200.00 $11.99

Share 13th Annual SoCalBio Conference

Event Details

The 13th Annual SoCalBio Conference will be held on November 9 at the Wilshire Grand Hotel in downtown Los Angeles. This event is held once a year to feature business presentations by CEOs of Southern California device, biotech, IVD and pharma firms interested in raising capital and/or forging strategic partnerships.  

Come to network with these companies and explore investment, partnerships and/or business development opportunities. Scroll down or click here to see the list of selected companies.


November 9, 2011

Wilshire Grand Hotel in Los Angeles, CA

Register for 13th Annual SoCalBio Conference in Los Angeles, United States  on Eventbrite

Sponsorship and Exhibit Opportunities Available

7:30 am

Registration & Breakfast

8:15 am

Introductions and Acknowledgment of Sponsors

  Tote Bag Sponsor



8:30 am

Morning Keynote Presentation 

Sponsored by


"The Competitiveness of the Greater Los Angeles ' Bioscience Industry Cluster," by Mitch Horowitz, PhD, Vice President & Managing Director, Battelle Technology Partnership Practice

Dr Horowitz will examine recent trends on the competitiveness of the Greater Los Angeles/Orange County Bioscience Industry Cluster, through the recession in terms of industry growth and venture capital as well as putting into context the broader market drivers for biosciences development and the rise of global competition and its implications. This presentation will examine best practices in growing biosciences industry cluster and involve a discussion on the preparedness of the Greater Los Angeles region to advance its biosciences industry cluster. 

9:30 am



Emerging Company Presentations

Sierra Room

Los Angeles Room

Garden East

Garden West

9:45 am

MannKind Oncology  Company 

Cancer therapeutics

Lone Star Heart, Inc.

Therapies to preserve and restore adequate heart function in patients with congestive heart failure


 Rapid, sensitive, and portable ELISA platform for use anywhere antibody based testing can be done

Avita Medical 

Regenerative medicine for wound healing

10:00 am

Cold Genesys

 A novel therapy to target bladder cancer cells


Device to capture and retrieve clots and restore blood flow in the cerebral vasculature of patients suffering from an acute ischemic stroke


(Devices for lysis and nucleic acid extraction from microbial cells for PCR ready sample)

Kythera Biopharma 

Novel prescription products for the aesthetic market

10:15 am


Protein therapeutics for applications in oncology, hematology, and immunology


Implantable hearing aids

Maven Biotech 

Developing LFIRE™ - a flexible, cost-effective, high density imaging technology for the multiplexed, quantitative, label-free, real-time characterization of biomarker binding reactions

LyoTip, Inc. 

Lyophilized drug delivery

10:30 am

Paganini Biopharma

Novel monoclonal antibody treatment for triple negative breast cancer

Jet Lasik 

A device combining a modified collagen-coated contact lens with a layer of live cultured skin cells to act as a postoperative tissue transplant "bandage" in photorefractive keratectomy procedures 

Integrated Plasmonics 

Nano photonics research to develop a point-of-care device for low-cost, disposable, multiplexed, and label-free diagnostics

California Stem Cell Inc. 

Production of high purity human cells for therapeutic development and clinical application

10:45 am


11:00 am


Therapeutics for autoimmune diseases based on novel peptides which selectively inhibit multiple cytokines without compromising the rest of the immune system


small, low-cost, and accurate pumps for subcutaneous drug delivery

DxTerity Diagnostics

Developing its patented NEAT™ platform to provide a pathway to incorporate genetic testing into routine medical care

OlFactor Laboratories 

Novel masking agents to protect animals and humans from vector borne diseases

11:15 am

Allegro Ophthalmic

Integrin peptide therapy for retinal vascular diseases, including  wet age-related macular  degeneration and diabetic macular edema


Light therapy devices for the treatment of dermatological and muscular/skeletal conditions

Oracle Bioscience

Biomarkers for triple negative breast cancer diagnosis


A cheminformatics company offering products and services for the pharmaceutical industry

11:30 am


Monoclonal antibody-based therapeutics to treat cancer, autoimmune disorders and other diseases


Medical devices to treat a broad array of commonly encountered skin lesions

Eye Predict

Assessing brain disorders with gaze measures

SMRT Therapeutics 

Small molecules for treating genetic diseases

11:45 am

ImmunoCellular Therapeutics

Immuno-therapeutics for brain cancer


Inexpensive, handheld diagnostic ultrasound devices

Ikona Medical

Image probe for diagnostic assessment of women suffering from abnormal uterine bleeding.

Vascular Access Systems 

Automated device allowing researchers to more efficiently make injections in mice through their tails)

12:00 noon


A proprietary stem cell platform for targeted therapeutic delivery to cancer cells


 Bi-modal functional Ultrasound platform for breast cancer screening and diagnosis

Reflectance Medical

 physiologic sensor to enable physicians to quickly assess a patient's metabolic status

Sira Technologies 

Cold chain temperature management solutions for food, pharmaceuticals, and other perishables

12:45 pm

Lunch & Keynote Presentations 

Sponsored by


1:00 pm

"Canada-California: A Partnership for Innovation and Economic Growth," By David Fransen, Consul General of Canada in Los Angeles

1:20 pm

"Breakthrough Cancer Coalition for FDA Reform," by Jonathan Lasch, PhD, Director, AMI - USC

1:30 pm

"Creating Entrepreneurial Universities to Fuel Regional Economic Growth," by Kalyanam Shivkumar MD, PhD, Professor of Medicine & Radiology and Director, UCLA Cardiac Arrhythmia Center & EP Programs, UCLA Health System

2:30  pm



Breakout Sessions: Resources for Entrepreneurs

2:45 pm

Sierra Room 

What to Expect from Patent Reform

Los Angeles Room

How to Effectively Secure Angel Money

Garden East Room

Effective Fund Raising Strategies in the Current Environment

Sponsored by

Sponsored by


Sponsored by

 Perkins Coie -- a leading bioscience lP and transaction law firm - will provide a primer on the various facets of "The America Invents Act"   and what they mean for inventors, Investors and small companies 

  • Michael Wise, Partner, Perkins Coie
  • Chris Fuglesang, PhD Direcor, Tavistock Life Sciences
  • Others TBA

 Representatives of Techcoast Angels, Pasadena Angels and Maverick Angels will discuss how to raise angel funding in Southern California


  • Jerry Knotts, President, Central Coast Venture Forum
  • Michael Sanders, Partner, Reed Smith
  • Bruce Blomstrom, Member, Pasadena Angels
  • Robin Campbell, Member, Maverick Angels  
  • Toni Gray, Member, Tech Coast Angels
  • Mike Savin, Member, Maverick Angels
  • Dimitri Villard, Memver, Tech Coast Angel

This panel will explore some of the unique funding challenges facing all new entrepreneurs. It will also touch on some of the additional challenges that women may face in seeking funding. 


  • Molly Schmid, PhD, KGI and Tech Coast Angels
  • Sanjesh P. Sharma, Partner, Chen Yoshimura LLP
  • Stephen Block,  Managing Director, Venture Farm, LLC
  • Jon Garfield, Chairman of the Advisory Board, OneMedPlace
  • Toni DasGupta, Ph. D. Managing Partner, Paradigm Select Assets, LLC
  • France Dixon Helfer, President & CEO Epic Medical, Inc.
  • Raulee Marcus, President Pinnacle Management
4:00 pm


4:15 pm

 Workshop on Securing SBIR & STTR Grant Funding for your Emerging Bioscience Company 

Sponsored by

Dr Greg Milman from the NIH and David Hood of DH3 Consulting will lead this workshop which will:

·          Provide updates on funding opportunities from both the NIH and DoD

·          Sharpen your grant-writing skills and

·          Teach you how to tap various government funding opportunities.

5:30 pm

Closing Reception and Poster Display 

Sponsored by  


7:00 pm

Conference Adjourns

Have questions about 13th Annual SoCalBio Conference? Contact Southern California Biomedical Council
Attendee List Sort by: Date | First Name | Last Name
Show More

When & Where

930 Wilshire Blvd
Los Angeles, 90017

Wednesday, November 9, 2011 from 7:00 AM to 7:00 PM (PST)

  Add to my calendar


Southern California Biomedical Council

The Southern California Biomedical Council is a nonprofit, member-supported trade association that supports and promotes life-science research, development, manufacturing, job creation and overall economic growth in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino). The Council’s programs help local firms gain access to capital, potential partners and business support services. SoCalBio also promotes technology transfer and workforce training, while informing policy makers and the public at-large about the benefits of the region’s life-science industry.  SoCalBio is open to membership by firms and organizations engaged in life-science technology development and commercialization. More information is available at http://www.socalbio.org
  Contact the Organizer
13th Annual SoCalBio Conference
Los Angeles Events Conference
Southern California Biomedical Council (SoCalBio) 444 South Flower Street, 34th Fl., Los Angeles, CA 90071 -- Phone: 213-236-4890 -- Fax: 213-403-7688 -- Email: scbc@socalbio.org -- Web: www.socalbio.org

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.